ClinicalTrials.gov record
Completed No phase listed Observational

MLX/XLX ACR Expandable Lumbar Interbody Implants

ClinicalTrials.gov ID: NCT04420143

Public ClinicalTrials.gov record NCT04420143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Assessment of the Safety and Performance of the MLX® Medial Lateral and XLX ACR® Expandable Lumbar Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Thoracic and/or Lumbar Spine

Study identification

NCT ID
NCT04420143
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
NuVasive
Industry
Enrollment
109 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 26, 2020
Primary completion
Oct 22, 2020
Completion
Oct 22, 2020
Last update posted
Dec 21, 2025

2020

United States locations

U.S. sites
4
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
Orthopaedic Specialty Institute Orange California 92868
Lyerly Neurosurgery Jacksonville Florida 32207
Carolina NeuroSurgery & Spine Associates Charlotte North Carolina 28204
OrthoCarolina Research Institute Charlotte North Carolina 28207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04420143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2025 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04420143 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →